The company said its shot generated an 8.7-fold increase in neutralising antibodies in humans against BA.2.86, which is being tracked by the World Health Organisation (WHO) and the U.S. Centers for Disease Control and Prevention (CDC).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment